Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal - PubMed (original) (raw)
. 1996 May 1;56(9):2039-44.
Affiliations
- PMID: 8616848
Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal
P Briand et al. Cancer Res. 1996.
Abstract
We have reported previously on the first spontaneously immortalized, nonmalignant human breast epithelial cell line, HMT-3522, which is entirely dependent on exogenous epidermal growth factor (EGF). In passage 118, cells were adapted to grow in medium without EGF and a new growth-transformed subline, HMT-3522/gt-1, was generated and propagated at high growth rate without exogenous EGF (Madsen et al., Cancer Res., 52: 1210-1217, 1992). Here we have used this subline and the continuum of the parent line, HMT-3522/wt, to pose the question whether a relevant change in a physiological parameter of the microenvironment will induce malignant transformation. The two cell lines were cultured under identical conditions with the only exception that EGF was omitted in the medium for gt-1. Initially, wt and gt-1 were identical in terms of karyotype as well as morphology, growth rate, and protein expression as revealed by two-dimensional gel electrophoresis. A highly dramatic shift to phenotype was observed in passage 238 when the gt-1 line became tumorigenic in nude mice. After two mouse-culture passages, the resulting malignantly transformed cell line (HMT-3522/mt-1) was refractory to the growth-modulating effect of EGF and presented an extra copy of a chromosome marker, 7q-, as the only cytogenetic difference from the gt-1. Our results suggest that microenvironmental cues are powerful factors in the induction of malignancy. A major role of EGF receptor in the malignant transformation is emphasized by loss of EGF sensitivity and acquisition of an extra chromosome 7p harboring the EGF receptor gene. We hypothesize that during premalignant hyperplasia, a population of EGF/transforming growth factor alpha autonomous epithelial cells in situ may develop as a consequence of local transforming growth factor alpha deprivation, a condition reflected in the culture model as autonomy after EGF withdrawal.
Similar articles
- Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements.
Madsen MW, Lykkesfeldt AE, Laursen I, Nielsen KV, Briand P. Madsen MW, et al. Cancer Res. 1992 Mar 1;52(5):1210-7. Cancer Res. 1992. PMID: 1737382 - Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS, Perroteau I, Kidwell WR, Tam J, Derynck R. Salomon DS, et al. J Cell Physiol. 1987 Mar;130(3):397-409. doi: 10.1002/jcp.1041300313. J Cell Physiol. 1987. PMID: 3494020 - The development of a functionally relevant cell culture model of progressive human breast cancer.
Weaver VM, Howlett AR, Langton-Webster B, Petersen OW, Bissell MJ. Weaver VM, et al. Semin Cancer Biol. 1995 Jun;6(3):175-84. doi: 10.1006/scbi.1995.0021. Semin Cancer Biol. 1995. PMID: 7495986 Review.
Cited by
- Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies.
Goddard ET, Linde MH, Srivastava S, Klug G, Shabaneh TB, Iannone S, Grzelak CA, Marsh S, Riggio AI, Shor RE, Linde IL, Guerrero M, Veatch JR, Snyder AG, Welm AL, Riddell SR, Ghajar CM. Goddard ET, et al. Cancer Cell. 2024 Jan 8;42(1):119-134.e12. doi: 10.1016/j.ccell.2023.12.011. Cancer Cell. 2024. PMID: 38194912 - Δ133p53 coordinates ECM-driven morphogenesis and gene expression in three-dimensional mammary epithelial acini.
Lee SY, Robertson C, Diot A, Meuray V, Bourdon JC, Bissell MJ. Lee SY, et al. J Cell Sci. 2022 Nov 1;135(21):jcs259673. doi: 10.1242/jcs.259673. Epub 2022 Nov 4. J Cell Sci. 2022. PMID: 36239052 Free PMC article. - Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brain.
Dai J, Cimino PJ, Gouin KH 3rd, Grzelak CA, Barrett A, Lim AR, Long A, Weaver S, Saldin LT, Uzamere A, Schulte V, Clegg N, Pisarsky L, Lyden D, Bissell MJ, Knott S, Welm AL, Bielas JH, Hansen KC, Winkler F, Holland EC, Ghajar CM. Dai J, et al. Nat Cancer. 2022 Jan;3(1):25-42. doi: 10.1038/s43018-021-00297-3. Epub 2021 Dec 24. Nat Cancer. 2022. PMID: 35121993 Free PMC article. - The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings.
Shor RE, Dai J, Lee SY, Pisarsky L, Matei I, Lucotti S, Lyden D, Bissell MJ, Ghajar CM. Shor RE, et al. Mol Oncol. 2022 Jan;16(1):130-147. doi: 10.1002/1878-0261.13031. Epub 2021 Jun 25. Mol Oncol. 2022. PMID: 34058066 Free PMC article. - Reduced Basal Nitric Oxide Production Induces Precancerous Mammary Lesions via ERBB2 and TGFβ.
Ren G, Zheng X, Bommarito M, Metzger S, Walia Y, Letson J, Schroering A, Kalinoski A, Weaver D, Figy C, Yeung K, Furuta S. Ren G, et al. Sci Rep. 2019 Apr 30;9(1):6688. doi: 10.1038/s41598-019-43239-x. Sci Rep. 2019. PMID: 31040372 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous